{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:25:04Z","timestamp":1749792304248,"version":"3.41.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiology Case Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.radcr.2025.04.124","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:20:49Z","timestamp":1747959649000},"page":"3977-3981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute pancreatitis caused by ceftriaxone-associated biliary pseudolithiasis in an older patient: A case report and literature review"],"prefix":"10.1016","volume":"20","author":[{"given":"Shoichi","family":"Nakazuru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naho","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Bessho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.radcr.2025.04.124_bib0001","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00006454-198611000-00026","article-title":"Transient formation of precipitations in the gallbladder associated with ceftriaxone therapy","volume":"5","author":"Schaad","year":"1986","journal-title":"Pediatr Infect Dis"},{"issue":"8625","key":"10.1016\/j.radcr.2025.04.124_bib0002","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(88)90596-X","article-title":"Reversible ceftriaxone-associated biliary pseudolithiasis in children","volume":"2","author":"Schaad","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.radcr.2025.04.124_bib0003","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.20.5.634","article-title":"Pharmacokinetics of ceftriaxone in humans","volume":"20","author":"Patel","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.radcr.2025.04.124_bib0004","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00606428","article-title":"Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose","volume":"22","author":"McNamara","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0005","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.25.4.438","article-title":"Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment","volume":"25","author":"Patel","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0006","first-page":"167","article-title":"High biliary elimination of ceftriaxone in man","volume":"26","author":"Brogard","year":"1988","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"6","key":"10.1016\/j.radcr.2025.04.124_bib0007","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/0016-5085(90)90486-K","article-title":"Pathogenesis of ceftriaxone-associated biliary sludge. In vitro studies of calcium-ceftriaxone binding and solubility","volume":"99","author":"Shiffman","year":"1990","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.radcr.2025.04.124_bib0008","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/0016-5085(91)90667-A","article-title":"Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate","volume":"100","author":"Park","year":"1991","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.radcr.2025.04.124_bib0009","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1651-2227.1999.tb01050.x","article-title":"Incidence of ceftriaxone-associated gallbladder pseudolithiasis","volume":"88","author":"Papadopoulou","year":"1999","journal-title":"Acta Paediatr"},{"issue":"6","key":"10.1016\/j.radcr.2025.04.124_bib0010","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1055\/s-2008-1072393","article-title":"Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children","volume":"10","author":"Bonnet","year":"2000","journal-title":"Eur J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.radcr.2025.04.124_bib0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/02841850510015983","article-title":"Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children","volume":"46","author":"Ozturk","year":"2005","journal-title":"Acta Radiol"},{"issue":"5","key":"10.1016\/j.radcr.2025.04.124_bib0012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jcu.20228","article-title":"Ceftriaxone-associated biliary pseudolithiasis in children","volume":"34","author":"Biner","year":"2006","journal-title":"J Clin Ultrasound"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0013","first-page":"404","article-title":"Biliary precipitation during ceftriaxone therapy: frequency and risk factors","volume":"49","author":"Soysal","year":"2007","journal-title":"Turk J Pediatr"},{"issue":"2","key":"10.1016\/j.radcr.2025.04.124_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.anpedi.2013.04.001","article-title":"Gallstones in association with the use of ceftriaxone in children","volume":"80","author":"Rodr\u00edguez Rangel","year":"2014","journal-title":"An Pediatr (Barc)"},{"issue":"5","key":"10.1016\/j.radcr.2025.04.124_bib0015","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/ped.12625","article-title":"Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis","volume":"57","author":"Murata","year":"2015","journal-title":"Pediatr Int"},{"issue":"8655","key":"10.1016\/j.radcr.2025.04.124_bib0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(89)90228-6","article-title":"Ceftriaxone-associated biliary pseudolithiasis in adults","volume":"2","author":"Pigrau","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0017","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/25.4.689","article-title":"Incidence of gallbladder lithiasis after ceftriaxone treatment","volume":"25","author":"Cometta","year":"1990","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.radcr.2025.04.124_bib0018","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1128\/AAC.34.6.1146","article-title":"Apparent biliary pseudolithiasis during ceftriaxone therapy","volume":"34","author":"Heim-Duthoy","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.radcr.2025.04.124_bib0019","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s11604-019-00893-5","article-title":"Computed tomography findings of ceftriaxone-associated biliary pseudocholelithiasis in adults","volume":"37","author":"Yoshida","year":"2019","journal-title":"Jpn J Radiol"},{"issue":"1","key":"10.1016\/j.radcr.2025.04.124_bib0020","first-page":"50","article-title":"Risk factors leading to ceftriaxone-associated biliary pseudolithiasis in children","volume":"19","author":"Kong","year":"1996","journal-title":"Changgeng Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.radcr.2025.04.124_bib0021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199001183220301","article-title":"A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children","volume":"322","author":"Schaad","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0022","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/1744-9987.13445","article-title":"Hemodialysis as a risk factor for ceftriaxone-associated pseudolithiasis in adults","volume":"24","author":"Ubukata","year":"2020","journal-title":"Ther Apher Dial"},{"issue":"24","key":"10.1016\/j.radcr.2025.04.124_bib0023","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.2169\/internalmedicine.7611-21","article-title":"Ceftriaxone-associated pseudolithiasis in elderly people: frequency and risk factors","volume":"60","author":"Hotta","year":"2021","journal-title":"Intern Med"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0024","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000529522","article-title":"Risk factors for Ceftriaxone-associated pseudolithiasis in adults","volume":"104","author":"Matsumi","year":"2023","journal-title":"Digestion"},{"key":"10.1016\/j.radcr.2025.04.124_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/DHPS.S183892","article-title":"Ceftriaxone-associated nephrolithiasis and gallstone in adults","volume":"10","author":"Azarkar","year":"2018","journal-title":"Drug Healthc Patient Saf"},{"issue":"3","key":"10.1016\/j.radcr.2025.04.124_bib0026","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10157-017-1493-7","article-title":"Risk factors of ceftriaxone-associated biliary pseudolithiasis in adults: influence of renal dysfunction","volume":"22","author":"Imafuku","year":"2018","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"10.1016\/j.radcr.2025.04.124_bib0027","first-page":"1251","article-title":"Reversible symptomatic biliary obstruction associated with ceftriaxone pseudolithiasis","volume":"86","author":"Zinberg","year":"1991","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"10.1016\/j.radcr.2025.04.124_bib0028","doi-asserted-by":"crossref","first-page":"712","DOI":"10.7326\/0003-4819-115-9-712","article-title":"Ceftriaxone-induced cholelithiasis","volume":"115","author":"Lopez","year":"1991","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.radcr.2025.04.124_bib0029","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/00006454-199807000-00022","article-title":"Gallstone pancreatitis caused by ceftriaxone","volume":"17","author":"Maranan","year":"1998","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.radcr.2025.04.124_bib0030","first-page":"202","article-title":"Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication","volume":"14","author":"Famularo","year":"1999","journal-title":"Ann Ital Med Int"},{"issue":"4","key":"10.1016\/j.radcr.2025.04.124_bib0031","first-page":"569","article-title":"Acute pancreatitis associated with the administration of ceftriaxone in an adult patient","volume":"106","author":"Sasaki","year":"2009","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"10.1016\/j.radcr.2025.04.124_bib0032","doi-asserted-by":"crossref","first-page":"3835825","DOI":"10.1155\/2017\/3835825","article-title":"Usefulness of endoscopic managements in patients with ceftriaxone-induced pseudolithiasis causing biliary obstruction","volume":"2017","author":"Doi","year":"2017","journal-title":"Case Rep Med"},{"issue":"23","key":"10.1016\/j.radcr.2025.04.124_bib0033","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.2169\/internalmedicine.8826-17","article-title":"Progressive pseudolithiasis associated with the intravenous administration of Ceftriaxone in patients with Central nervous system infections","volume":"56","author":"Tsukagoshi","year":"2017","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.radcr.2025.04.124_bib0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radcr.2017.10.022","article-title":"Ceftriaxone-associated pancreatitis captured on serial computed tomography scans","volume":"13","author":"Nakagawa","year":"2017","journal-title":"Radiol Case Rep"},{"issue":"3","key":"10.1016\/j.radcr.2025.04.124_bib0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/ggi.13245","article-title":"Ceftriaxone and pseudolithiasis in older people","volume":"18","author":"Miyamoto","year":"2018","journal-title":"Geriatr Gerontol Int"},{"issue":"3","key":"10.1016\/j.radcr.2025.04.124_bib0036","first-page":"149","article-title":"Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report","volume":"33","author":"Sienra","year":"2020","journal-title":"Cir Pediatr"},{"issue":"6","key":"10.1016\/j.radcr.2025.04.124_bib0037","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.gie.2018.10.001","article-title":"ASGE Standards of Practice Committee. ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis","volume":"89","author":"Buxbaum","year":"2019","journal-title":"Gastrointest Endosc"}],"container-title":["Radiology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043325004182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1930043325004182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T11:16:51Z","timestamp":1749295011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1930043325004182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1930043325004182"],"URL":"https:\/\/doi.org\/10.1016\/j.radcr.2025.04.124","relation":{},"ISSN":["1930-0433"],"issn-type":[{"type":"print","value":"1930-0433"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute pancreatitis caused by ceftriaxone-associated biliary pseudolithiasis in an older patient: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Radiology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radcr.2025.04.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of University of Washington.","name":"copyright","label":"Copyright"}]}}